DK155174C - Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel - Google Patents

Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel

Info

Publication number: DK155174C
Authority: DK; Denmark
Prior art keywords: procedure; preparation; immunosuppressive agent; therapeutic immunosuppressive; therapeutic
Prior art date: 1977-02-03

Application number

DK049178A

Other languages

English (en)

Other versions

DK155174B (da

DK49178A (da

Inventor

David Harvey Katz

Original Assignee

Scripps Clinic Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-02-03

Filing date

1978-02-02

Publication date

1989-07-10

1978-02-02 Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res

1978-08-04 Publication of DK49178A publication Critical patent/DK49178A/da

1989-02-27 Publication of DK155174B publication Critical patent/DK155174B/da

1989-07-10 Application granted granted Critical

1989-07-10 Publication of DK155174C publication Critical patent/DK155174C/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S524/90—Antigen-antibody
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Transplantation (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK049178A 1977-02-03 1978-02-02 Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel DK155174C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US05/764,586 US4191668A (en)	1977-02-03	1977-02-03	Induction of immunological tolerance
US76458677		1977-02-03

Publications (3)

Publication Number	Publication Date
DK49178A DK49178A (da)	1978-08-04
DK155174B DK155174B (da)	1989-02-27
DK155174C true DK155174C (da)	1989-07-10

Family

ID=25071153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK049178A DK155174C (da)	1977-02-03	1978-02-02	Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel

Country Status (17)

Country	Link
US (1)	US4191668A (da)
JP (1)	JPS53121943A (da)
AU (1)	AU515181B2 (da)
BE (1)	BE863656A (da)
CA (1)	CA1118347A (da)
CH (1)	CH644521A5 (da)
DE (1)	DE2804457C2 (da)
DK (1)	DK155174C (da)
FI (1)	FI780312A (da)
FR (1)	FR2379287A1 (da)
GB (1)	GB1599454A (da)
LU (1)	LU78997A1 (da)
MX (1)	MX6266E (da)
NL (1)	NL7801220A (da)
NO (1)	NO153419C (da)
SE (1)	SE464616B (da)
ZA (1)	ZA78613B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4220565A (en) *	1979-01-18	1980-09-02	Scripps Clinic & Research Foundation	Immunochemical conjugates: method and composition
US4276206A (en) *	1979-01-18	1981-06-30	Scripps Clinic & Research Foundation	Immunochemical conjugates: method and composition
US4253995A (en) *	1980-02-11	1981-03-03	Scripps Clinic And Research Foundation	Immunochemical conjugates: method and composition
US4253996A (en) *	1980-02-13	1981-03-03	Scripps Clinic And Research Foundation	Immunochemical conjugates: method and composition
DE3114362C2 (de) *	1980-04-11	1983-08-18	Toshiyuki Prof. Nara Hamaoka	Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung
EP0077158A1 (en) *	1981-10-09	1983-04-20	Beecham Group Plc	Modified allergens
US5370871A (en) *	1983-01-24	1994-12-06	The Johns Hopkins University	Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5126131A (en) *	1983-01-24	1992-06-30	The Johns Hopkins University	Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US6022544A (en) *	1983-01-24	2000-02-08	The John Hopkins University	Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US4950713A (en) *	1986-05-30	1990-08-21	La Jolla Pharmaceutical Company	Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals
CA1309558C (en) *	1986-05-30	1992-10-27	Quidel	D-gl conjugate therapy
US4950469A (en) *	1986-05-30	1990-08-21	La Jolla Pharmaceutical Company	D-GL conjugate therapy
US5017648A (en) *	1986-05-30	1991-05-21	La Jolla Pharmaceutical Company	D-GL conjugate therapy
US5268454A (en) *	1991-02-08	1993-12-07	La Jolla Pharmaceutical Company	Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5552391A (en) *	1990-01-16	1996-09-03	La Jolla Pharmaceutical Company	Chemically-defined non-polymeric valency platform molecules and conjugates thereof
US5162515A (en) *	1990-01-16	1992-11-10	La Jolla Pharmaceutical Company	Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
US5391785A (en) *	1990-01-16	1995-02-21	La Jolla Pharmaceutial Company	Intermediates for providing functional groups on the 5' end of oligonucleotides
IE922292A1 (en) *	1991-07-15	1993-01-27	Jolla Pharma	Modified phosphorous intermediates for providing functional¹groups on the 5' end of oligonucleotides
KR100361933B1 (ko) *	1993-09-08	2003-02-14	라 졸라 파마슈티칼 컴파니	화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US8071737B2 (en)	1995-05-04	2011-12-06	Glead Sciences, Inc.	Nucleic acid ligand complexes
US5874409A (en)	1995-06-07	1999-02-23	La Jolla Pharmaceutical Company	APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6410775B1 (en) *	1995-06-07	2002-06-25	La Jolla Pharmaceutical Company	APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6858210B1 (en)	1998-06-09	2005-02-22	La Jolla Pharmaceutical Co.	Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6399578B1 (en)	1998-12-09	2002-06-04	La Jolla Pharmaceutical Company	Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US6458953B1 (en) *	1998-12-09	2002-10-01	La Jolla Pharmaceutical Company	Valency platform molecules comprising carbamate linkages
US7084256B2 (en) *	1999-09-24	2006-08-01	Large Scale Biology Corporation	Self antigen vaccines for treating B cell lymphomas and other cancers
US20030044420A1 (en) *	1999-09-24	2003-03-06	Mccormick Alison A.	Self antigen vaccines for treating B cell lymphomas and other cancers
CA2414076A1 (en)	2000-06-08	2001-12-13	La Jolla Pharmaceutical Company	Multivalent platform molecules comprising high molecular weight polyethylene oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3825525A (en) *	1969-08-06	1974-07-23	Beecham Group Ltd	Allergens reacted with carbodiimides
GB1282163A (en) *	1969-08-06	1972-07-19	Beecham Group Ltd	Modified allergens and a process for their preparation

1977
- 1977-02-03 US US05/764,586 patent/US4191668A/en not_active Expired - Lifetime
1978
- 1978-01-31 FI FI780312A patent/FI780312A/fi not_active Application Discontinuation
- 1978-01-31 CA CA000295952A patent/CA1118347A/en not_active Expired
- 1978-02-01 ZA ZA00780613A patent/ZA78613B/xx unknown
- 1978-02-02 GB GB4310/78A patent/GB1599454A/en not_active Expired
- 1978-02-02 NO NO780366A patent/NO153419C/no unknown
- 1978-02-02 JP JP1105378A patent/JPS53121943A/ja active Granted
- 1978-02-02 SE SE7801268A patent/SE464616B/xx unknown
- 1978-02-02 DE DE2804457A patent/DE2804457C2/de not_active Expired
- 1978-02-02 DK DK049178A patent/DK155174C/da not_active IP Right Cessation
- 1978-02-02 NL NL7801220A patent/NL7801220A/xx not_active Application Discontinuation
- 1978-02-03 BE BE184908A patent/BE863656A/xx not_active IP Right Cessation
- 1978-02-03 CH CH124078A patent/CH644521A5/de not_active IP Right Cessation
- 1978-02-03 LU LU78997A patent/LU78997A1/xx unknown
- 1978-02-03 FR FR7803063A patent/FR2379287A1/fr active Granted
- 1978-02-03 MX MX786822U patent/MX6266E/es unknown
- 1978-02-05 AU AU32933/78A patent/AU515181B2/en not_active Expired

Also Published As

Publication number	Publication date
JPS53121943A (en)	1978-10-24
FR2379287B1 (da)	1980-08-29
DK155174B (da)	1989-02-27
AU3293378A (en)	1979-08-09
NO780366L (no)	1978-08-04
AU515181B2 (en)	1981-03-19
LU78997A1 (fr)	1978-06-21
CA1118347A (en)	1982-02-16
FR2379287A1 (fr)	1978-09-01
JPH0428689B2 (da)	1992-05-15
NO153419C (no)	1986-03-19
NL7801220A (nl)	1978-08-07
SE464616B (sv)	1991-05-27
GB1599454A (en)	1981-10-07
MX6266E (es)	1985-02-27
BE863656A (fr)	1978-05-29
ZA78613B (en)	1978-12-27
SE7801268L (sv)	1978-08-04
US4191668A (en)	1980-03-04
DE2804457C2 (de)	1984-04-12
CH644521A5 (de)	1984-08-15
DE2804457A1 (de)	1978-08-10
DK49178A (da)	1978-08-04
NO153419B (no)	1985-12-09
FI780312A (fi)	1978-08-04

Publication	Publication Date	Title
DK155174C (da)	1989-07-10	Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel
DK151931C (da)	1988-06-06	Fremgangsmaade til fremstilling af et farmacentisk praeparat i enhedsdosisform
DK536178A (da)	1979-06-23	Fremgangsmaade til fremstilling af stilbenderivater
DK110778A (da)	1978-09-15	Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer
DK306978A (da)	1979-01-12	Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner
DK569678A (da)	1979-06-21	Fremgangsmaade til fremstilling af 2alfa-cyano-3-oxosteroider
DK484677A (da)	1979-04-04	Fremgangsmaade til fremstilling af furokumariner
DK145701C (da)	1983-07-18	Fremgangsmaade til fremstilling af ergotalkaloider
DK466878A (da)	1979-04-21	Fremgangsmaade til fremstilling af 0-methallyloxyphenol
DK237978A (da)	1979-01-19	Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer
DK352578A (da)	1979-02-10	Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK154949C (da)	1989-05-29	Fremgangsmaade til fremstilling af trifluormethylphenoler
DK436978A (da)	1979-04-05	Fremgangsmaade til fremstilling af sarcosinoxidase
DK577078A (da)	1979-06-28	Fremgangsmaade til fremstilling af trans-4a-aryloctahydro-1h-2-pyridiner
DK5778A (da)	1978-07-12	Femgangsmaade til fremstilling af 4-diphenylmethylen-1-hydroxybenzyl-piperidiner
DK295378A (da)	1979-01-05	Fremgangsmaade til fremstilling af terapeutisk virksomme diarylalkylaminer
DK364578A (da)	1979-02-19	Fremgangsmaade til fremstilling af hydroxyphenylhydantoin
DK529278A (da)	1979-06-04	Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere
DK248978A (da)	1978-12-05	Fremgangsmaade til fremstilling af hydroxy-alfa-aminobenzylpenicillin
DK246878A (da)	1978-12-04	Fremgangsmaade til fremstilling af acylderivater
DK339777A (da)	1978-10-30	Fremgangsmaade til fremstilling af 2-benzylperhydroazepiner
DK383978A (da)	1979-03-02	Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidin-4-oner
DK441878A (da)	1979-04-08	Fremgangsmaade til fremstilling af bibenzylderivater
DK28078A (da)	1978-07-21	Fremgangsmaade til fremstilling af et tetraalkylthiuramdisulfid
DK158976C (da)	1990-12-31	Fremgangsmaade til fremstilling af alfa-cyanobenzyl

Legal Events

Date	Code	Title	Description
1992-10-26	PBP	Patent lapsed